Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease
Kei Nishioka, Haruei Ogino, Takatoshi Chinen, Eikichi Ihara, Yoshimasa Tanaka, Kazuhiko Nakamura, Yoshihiro Ogawa
Topics & Concepts
MedicineUstekinumabInflammatory bowel diseaseImmunologyTumor necrosis factor alphaInternal medicineInterleukin 23Surgical oncologyIntestinal mucosaBiopsyCrohn's diseaseGastroenterologyInterleukinDiseaseInfliximabCytokineInflammatory Bowel DiseasePsoriasis: Treatment and PathogenesisCytokine Signaling Pathways and Interactions